Pediatric Exposures to Persistent Environmental Chemicals
DOI:
https://doi.org/10.17140/PNNOJ-1-e001Abstract
Traditional risk factors are responsible for about 70% of the population attributable
risk of Cardiovascular Disease (CVD).1 Common environmental exposures are known to be
responsible for some portion of the remaining 30%. Therefore, it is important to study chemicals
like the class known as Perfluoroalkyl Chemicals (PFCs) or Perfluoroalkyl Substances
(PSASs). Two of the most highly studied PFCs are Perfluorooctanoic Acid (PFOA or C8) and
Perfluorooctane Sulfonate (PFOS or C8S). PFCs are persistent in the environment and associations
have been shown with a whole host of negative health outcomes in laboratory animals,
including endocrine-disrupting properties as well as developmental effects.2 To make matters
worse, PFCs have been detected in the blood of >98% of the US population3 and epidemiological
studies have demonstrated associations between PFOA and PFOS, and many negative
health outcomes such as cancer,4 CVD,5 osteoarthritis,6 hyperuricemia,7 pregnancy-induced
hypertension,8 endocrine disruption,9 dyslipidemia,10,11 and reproductive effects,12,13 often times
even at baseline levels typical of the general population’s exposure level.
References
Willett WC. Balancing life-style and genomics research for disease prevention. Science. 2002; 26: 296(5568): 695-698. doi: 10.1126/science.1071055
American Heart Association. Heart Disease and Stroke Sta-tistics: 2006 Update Dallas, TX. Website: https://circ.ahajour-nals.org/content/113/6/e85.extract. 2006; Accessed May 27, 2009.
Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999- 2000. Environ Health Perspect. 2007; 115(11): 1596-1602. doi: 10.1289/ehp.10598
Eriksen KT, Sorensen M, McLaughlin JK et al. Perfluorooc-tanoate and perfluorooctanesulfonate plasma levels and risk of cancer in the general Danish population. J Natl Cancer Inst. 2009; 15: 101(8): 605-609. doi: 10.1093/jnci/djp041
Sakr CJ, Symons JM, Kreckmann KH, Leonard RC. Ischaemic heart disease mortality study among workers with occupational exposure to ammonium perfluorooctanoate. Occup Environ Med. 2009; 66(10): 699-703. doi: 10.1136/oem.2008.041582
Innes KE, Ducatman AM, Luster MI, Shankar A. Associa-tion of osteoarthritis with serum levels of the environmental contaminants perfluorooctanoate and perfluorooctane sulfonate in a large Appalachian population. Am J Epidemiol. 2011; 15: 174(4): 440-450. doi: 10.1093/aje/kwr107
Shankar A, Xiao J, Ducatman A. Perfluoroalkyl chemicals and elevated serum uric acid in US adults. Clin Epidemiol. 2011; 3: 251-258. doi: 10.2147/CLEP.S21677
C8 Science Panel. Probable Link Evaluation of Pregnancy Induced Hypertension and Preeclampsia. Website: http://www. c8sciencepanel.org/pdfs/Probable_Link_C8_PIH_5Dec2011. pdf. 2012; Accessed February 1, 2012.
Olsen GW, Zobel LR. Assessment of lipid, hepatic, and thy-roid parameters with serum perfluorooctanoate (PFOA) con-centrations in fluorochemical production workers. Int Arch Occup Environ Health. 2007; 81(2): 231-246. doi: 10.1007/ s00420-007-0213-0
Sakr CJ, Kreckmann KH, Green JW, Gillies PJ, Reynolds JL, Leonard RC. Cross- sectional study of lipids and liver en-zymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers. J Occup Envi-ron Med. 2007; 49(10): 1086-1096. Pediatr Neonatal Nurs Open J
Frisbee SJ, Shankar A, Knox SS et al. Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project. Arch Pediatr Adolesc Med. 2010; 164(9): 860-869. doi: 10.1001/ archpediatrics.2010.163
Sakr CJ, Kreckmann KH, Green JW, Gillies PJ, Reynolds JL, Leonard RC. Cross- sectional study of lipids and liver en-zymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers. J Occup Envi-ron Med. 2007; 49(10): 1086-1096.
Joensen UN, Bossi R, Leffers H, et al. Do perfluoroalkyl compounds impair human semen quality? Environ Health Per-spect. 2009; 117(6): 923-927. doi: 10.1289/ehp.0800517
Daniels SR, Greer FR. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008; 122(1): 198-208. doi: 10.1542/peds.2008-1349
Frisbee SJ, Shankar A, Knox SS, et al. Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project. Arch Pediatr Adolesc Med. 2010; 164(9): 860-869.
Geiger SD, Xiao J, Ducatman A, et al. The association be-tween perfluoroalkyl chemicals and serum lipid levels in ado-lescents. Chemosphere. 2014; 98: 78-83.
Geiger SD, Xiao J, Shankar A. Positive association between perfluoroalkyl chemicals and hyperuricemia in children. Amer-ican Journal of Epidemiology. 2013; 177(11): 1255-1262. doi: 10.1093/aje/kws392
Hoffman K, Webster TF, Weisskopf MG, Weinberg J, Vie-ira VM. Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12- 15 years of age. Environ Health Perspect. 2010; 118(12): 1762-1767. doi: 10.1289/ehp.1001898 Page e2
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Pediatrics and Neonatal Nursing (PNN) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
